
Venture capital · Early stage
Frazier Life Sciences
Frazier Life Sciences is a healthcare-focused investment firm running venture and public equity strategies that back and build companies developing novel therapeutics. It has offices in Palo Alto, San Diego, Boston and Seattle.
Investment activity
Round-by-round activity is part of PRO
Key signal this week
Is Frazier Life Sciences right for your round?
Key stats
Fund cycle Public record
Fund vehicles on public registers (SEC adviser filings). Values are the gross assets each filing reports, not fund sizes.
Latest investments
BetaRounds Frazier Life Sciences joined, from press and the firm’s own posts.
3 rounds in the last 12 months
Round sizes, Frazier Life Sciences’s role and who invested alongside.
Notable portfolio
Portfolio and exits
Every company Frazier Life Sciences backed and how the exits played out.
Where the money goes
Share of companies at first investment, from the rounds we track.
Investment team
Where to meet Frazier Life Sciences
Events where Frazier Life Sciences’s team spoke or showed up, from event programmes, press and the firm’s own posts.
Signals
Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.
Founders also look at
Frequently asked questions
Frazier Life Sciences is based in Palo Alto, United States. It also has offices in San Diego, Boston and Seattle.
6 fund vehicles are on public registers (SEC adviser filings), including FRAZIER LIFE SCIENCES PUBLIC FUND, L.P., FRAZIER LIFE SCIENCES XII, L.P. and FRAZIER LIFE SCIENCES XI, L.P.
Stages: Series A. Sectors: Biotech, Life sciences. From the firm’s own website.
Invests in and builds product-focused biopharma companies able to produce meaningful clinical data or commercialize therapeutics. Venture strategy emphasizes company creation and Series A, preclinical-to-clinical, with significant equity ownership and long-term management partnerships. Public strategy is long-only, evergreen, covering listed small/mid-caps and crossover rounds. From the firm’s own website.
Frazier Life Sciences lists 50 portfolio companies on its website, including 35Pharma, Acerta Pharma, Achaogen, Adverum Biotechnologies and Airnexis Therapeutics.
Firms whose websites list some of the same companies include Longitude Capital, RA Capital and Alta Partners.
Know before Frazier Life Sciences’s next round is announced.
PRO tracks Frazier Life Sciences’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.